Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| OLN | 8-K | neutral | 5/10 | Olin Corporation entered into the Second Amendment to its Credit Agreement, establishing a new $750 million term loan fa | Oct 28, 2026 |
| USDE | 8-K | neutral | 2/10 | StableCoinX Inc. filed an 8-K to disclose an investor presentation posted to its website on October 28, 2026. The filing | Oct 28, 2026 |
| LNT | 8-K | bullish | 6/10 | Alliant Energy Corp's subsidiaries Wisconsin Power & Light and Interstate Power & Light each entered into separate loan | Oct 28, 2026 |
| MSGY | SC 13D/A | neutral | 4/10 | Fung & Tun Ltd filed an amendment to its Schedule 13D for Masonglory Ltd, reporting a reduction in its Class A share pos | Oct 28, 2026 |
| RNW | SC 13D/A | neutral | 2/10 | Founder Sumant Sinha files Amendment No. 12 to Schedule 13D, entering into a side letter to the Transaction Agreement da | Oct 28, 2026 |
| ACMR | 8-K | bullish | 6/10 | ACM Research announced preliminary unaudited Q3 2026 revenue of $360M-$365M (34%-36% YoY growth) and preliminary total s | Oct 28, 2026 |
| GEVO | 8-K | neutral | 2/10 | Gevo appointed KLynne Johnson to its Board of Directors as a Class II director, effective November 4, 2026. Johnson brin | Oct 28, 2026 |
| OSS | 8-K | bullish | 6/10 | One Stop Systems reported Q3 2026 revenue of $12.6M, up 35.9% YoY, above the $10.9M consensus. GAAP EPS was -$0.02, miss | Oct 28, 2026 |
| TDTH | PRESS-RELEASE | neutral | 4/10 | Trident Digital Tech CEO Soon Huat Lim announced an open-market purchase of up to 1,000,000 Class B ordinary shares at ≤ | Oct 28, 2026 |
| PRQR | 6-K | neutral | 3/10 | ProQR announced upcoming presentations of clinical and preclinical data for its RNA editing candidates AX-0810 and AX-08 | Oct 28, 2026 |
| ORN | 8-K | bullish | 6/10 | Orion Group Holdings reported Q3 2026 revenue of $256.2M (+14% YoY), GAAP EPS of $0.14 (vs $0.08 YoY), and Adjusted EPS | Oct 28, 2026 |
| PYPD | 6-K | neutral | 4/10 | PolyPid announced an expanded pipeline strategy, introducing PD01B, a new product candidate for diabetic foot infections | Oct 28, 2026 |
| BCAL | 8-K | neutral | 5/10 | California BanCorp reported Q3 2026 net income of $14.0M ($0.43 diluted EPS), down from $15.7M ($0.48) a year ago. Net i | Oct 28, 2026 |
| IPXG | 425 | neutral | 3/10 | Inflection Point Acquisition Corp. VII, IPGX Merger Sub, and Elroy Air entered into a First Amendment to their Business | Oct 28, 2026 |
| CHRW | 8-K | bullish | 6/10 | C.H. Robinson reported Q3 2026 results with total revenue up 29.5% to $5.36B and adjusted diluted EPS of $1.80, beating | Oct 28, 2026 |
| BNTC | 8-K | bullish | 6/10 | Benitec Biopharma announced positive interim Phase 1b/2a results for BB-301, its gene therapy for Oculopharyngeal Muscul | Oct 28, 2026 |
| EAT | 8-K | bullish | 6/10 | Brinker International reported Q1 fiscal 2027 results with total revenues of $1.4756B (up 9.4% YoY) and non-GAAP EPS of | Oct 28, 2026 |
| FELE | PRESS-RELEASE | bullish | 6/10 | Franklin Electric reported Q3 2026 adjusted EPS of $1.50, beating the $1.40 consensus, and revenue of $633.6M, above the | Oct 28, 2026 |
| OSS | PRESS-RELEASE | bullish | 6/10 | OSS reported Q3 2026 revenue of $12.6M, up 35.9% YoY and above the $10.9M consensus. Non-GAAP EPS of $0.01 matched the $ | Oct 28, 2026 |
| SNES | PRESS-RELEASE | neutral | 3/10 | SenesTech engaged Sandstrom Partners as a strategic advisor for brand development to accelerate sales of its rodent birt | Oct 28, 2026 |
| SCOR | PRESS-RELEASE | neutral | 3/10 | Comscore announced an expanded partnership with Magnite to integrate Proximic's Predictive Audiences and contextual inte | Oct 28, 2026 |
| ULCC | PRESS-RELEASE | bullish | 6/10 | Frontier reported Q3 2026 record revenue of $1.355B, up 53% YoY, and adjusted EPS of $0.18, significantly above the $-0. | Oct 28, 2026 |
| IPXG | 8-K | neutral | 4/10 | Inflection Point Acquisition Corp. VII, IPGX Merger Sub, and Elroy Air entered into a First Amendment to their Business | Oct 28, 2026 |
| ENLV | 6-K | neutral | 4/10 | Enlivex announced that 135 of 182 planned patients have been randomized and received the first injection in its Phase 2b | Oct 28, 2026 |
| PRQR | PRESS-RELEASE | neutral | 3/10 | ProQR announced upcoming presentations of clinical and preclinical data for its RNA editing programs AX-0810 and AX-0811 | Oct 28, 2026 |
| HNVR | PRESS-RELEASE | neutral | 5/10 | Hanover Bancorp reported Q3 2026 net income of $4.3M ($0.60 per diluted share), up from $3.5M ($0.47) a year ago, driven | Oct 28, 2026 |
| WING | PRESS-RELEASE | bearish | 6/10 | Wingstop reported Q3 2026 revenue of $185.1M (+5.3% YoY) and adjusted EPS of $1.08, beating the $1.02 consensus. However | Oct 28, 2026 |
| ACTU | 424B5 | bearish | 6/10 | Actuate Therapeutics priced a $11.0M underwritten offering of 30,985,900 common shares and 15,492,950 warrants (each two | Oct 28, 2026 |
| IMRN | 6-K | neutral | 2/10 | Immuron Ltd filed a 6-K furnishing an investor presentation from the Emerging Growth Conference. The presentation reiter | Oct 28, 2026 |
| FELE | 8-K | bullish | 6/10 | Franklin Electric reported Q3 2026 net sales of $633.6M (+9% YoY) and GAAP diluted EPS of $1.35 (+265% YoY, though prior | Oct 28, 2026 |